Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Non-Current Assets: 2009-2024

Historic Non-Current Assets for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $27.0 billion.

  • Fresenius Medical Care AG's Non-Current Assets rose 53.21% to $27.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $106.6 billion, marking a year-over-year decrease of 155.66%. This contributed to the annual value of $27.8 billion for FY2024, which is 225.12% up from last year.
  • As of Q3 2025, Fresenius Medical Care AG's Non-Current Assets stood at $27.0 billion, which was up 53.21% from $26.2 billion recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Non-Current Assets ranged from a high of $30.6 billion in Q1 2021 and a low of $26.1 billion during Q1 2025
  • For the 5-year period, Fresenius Medical Care AG's Non-Current Assets averaged around $28.4 billion, with its median value being $28.9 billion (2023).
  • As far as peak fluctuations go, Fresenius Medical Care AG's Non-Current Assets soared by 582.05% in 2021, and later plummeted by 731.47% in 2024.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Non-Current Assets stood at $28.9 billion in 2021, then decreased by 6.4% to $27.1 billion in 2022, then rose by 0.25% to $27.1 billion in 2023, then grew by 0.95% to $27.4 billion in 2024, then decreased by 1.61% to $27.0 billion in 2025.
  • Its Non-Current Assets stands at $27.0 billion for Q3 2025, versus $26.2 billion for Q2 2025 and $26.1 billion for Q1 2025.